Star Tribune

Alzheimer's drug that can slow disease gets backing from FDA advisers

The FDA will make the final decision on approval later this year. If the agency agrees with the panel's recommendation, the drug, donanemab, would only be the second Alzheimer's drug cleared in the ...
FOX31 Denver

Alzheimer’s drug that can slow disease gets backing from FDA advisers

WASHINGTON (AP) — A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with mild ...
The Telegraph

Alzheimer’s drug that can slow disease gets backing from FDA advisers

FILE - A sign for Eli Lilly & Co. sits outside their corporate headquarters in Indianapolis on April 26, 2017. A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health ...